background: Precise sperm -oocyte interaction is a critical event for successful fertilization. However, the identity of molecules involved in this process in humans remains largely unknown. This report describes the identification and characterization of a novel cellsurface protein and its potential role in human sperm -oocyte interaction. methods and results: We previously identified an orphan guanylyl cyclase receptor (mouse GC-G) highly enriched in mouse testis and involved in sperm activation. By using a comparative genomic approach, we found the homologue gene in human (hGC-G) composed of 21 exons, spanning a minimum of 48 kb on chromosome 10q25. Real-time RT -PCR analysis revealed hGC-G mRNA selectively expressed in testis but with low or no expression in all other tissues examined. Compared with mGC-G, the hGC-G transcript contains three 1-bp deletions and two in-frame termination codons, which results in a short putative receptor-like polypeptide. Western blot analysis with an anti-hGC-G-specific antibody confirmed the protein expression of hGC-G in human sperm lysate. Flow cytometry and confocal immunofluorescence analysis demonstrated the localization of hGC-G protein on the acrosome cap and equatorial segment of mature human sperm. In addition, an integrin-binding Arg-Gly-Asp (RGD) motif was found in the extracellular domain of hGC-G. Pre-incubation of the hGC-G RGD peptide with zona pellucida-free oocytes greatly decreased the binding of human sperm to hamster oocytes, which suggests a role for hGC-G role in sperm -oocyte interaction.
Introduction
In sexually reproductive species, the precise recognition between sperm and oocyte is the most important process in successful fertilization. Current evidence suggests that several molecules on the sperm cell surface interact with the oocyte to complete the sperm -oocyte interaction; examples are CD46 (membrane cofactor protein) (Anderson et al., 1993; Inoue et al., 2003) , mouse sperm lysozyme-like protein (mSLLP1) (Herrero et al., 2005) , epididymal-derived cysteine-rich secretory protein 1 (CRISP-1) (Cuasnicu et al., 1984; Da Ros et al., 2008) , ERp57 (Pdi3a) (Ellerman et al., 2006) , Izumo (Inoue et al., 2005) , and the three ADAMs (a disintegrin and metalloprotease domain) proteins. The ADAMs include fertilin a (ADAM1), fertilin b (ADAM2) and cyritestin (ADAM3), which are expressed on the sperm cell surface to provide an Arg-Gly-Asp (RGD) motif for interaction with integrins on the oocyte (Evans et al., 1995; Yuan et al., 1997; Primakoff and Myles, 2000) . Integrins are a family of cell adhesion molecules that mediate cell-cell and cell-extracellular matrix interaction. They exist as heterodimers, for which at least 18a and 8b subunits have been identified, and different subunit combinations give rise to 24 different integrins (Evans, 2002) . On the oocyte surface, the integrin of a6b1 has been implicated in both the ADAM2 and ADAM3 interaction in sperm (Bigler et al., 2000; Takahashi et al., 2001) . Although the possible mechanisms of † These authors contributed equally to this work. & The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.
For Permissions, please email: journals.permissions@oxfordjournals.org sperm -oocyte interaction have been reported for many species, gene-knockout of several of these molecules has not affected fertility or sperm -oocyte interaction (Cho et al., 1998; Nishimura et al., 2001; Inoue et al., 2003; Da Ros et al., 2008) . Furthermore, the recognition molecules on the human sperm surface are still not completely known.
Intracellular cyclic GMP (cGMP) acts a second messenger in the regulation of a broad spectrum of tissue functions, such as intestinal secretion, smooth-muscle relaxation, retinal phototransduction, platelet activation and sperm activation (Vaandrager and De Jonge, 1994; Warner et al., 1994; Schlossmann et al., 2003; Huang et al., 2006; Kuhn, 2009) . In mammals, the cGMP-generating enzymes [guanylyl cyclases (GCs)] are divided into two major classes: those that contain no apparent transmembrane segment (the soluble form) and those that contain one transmembrane segment (the receptor form) (Tamura et al., 2001) . To date, seven receptor GCs have been identified in mammals, termed GC-A to GC-G in order of their discovery (Chinkers et al., 1989; Lowe, et al., , 1995 Schulz et al., 1989 Schulz et al., , 1990 Schulz et al., , 1998 Koller et al., 1991; Shyjan et al., 1992; Fulle et al., 1995; Matsuoka et al., 1995; Kuhn et al., 2004; Kuhn, 2009 ). These proteins form a family of type I cell-surface receptors and share a common domain organization: an extracellular ligandbinding domain, a single membrane-spanning segment, and a cytoplasmic region that can be subdivided into a protein kinase-like domain and a carboxyl-terminal cyclase catalytic domain (Garbers, 1999; Kuhn, 2009 ). The peptide ligands have been identified for only four of the receptor GCs (GC-A, -B, -C and -D), and the other three membrane GCs remain known as orphan receptors (Kuhn, 2009) .
The mouse GC-G (mGC-G), the most recent member of the receptor GC family, was identified from the mouse testis (Kuhn et al., 2004) . mGC-G is highly and selectively expressed in mouse testis. All ligands known to activate other receptor GCs have failed to stimulate its enzymatic activity (Kuhn et al., 2004) . However, when overexpressed in human embryonic kidney (HEK)-293T cells, the recombinant mGC-G exhibits marked cGMP-generating GC activity. In addition, use of a specific neutralizing antibody demonstrated mGC-G to play an important role in regulation of sperm motility and capacitation (Huang et al., 2006) . Furthermore, under pathophysiological conditions, mGC-G has been found to contribute to tubular damage and renal failure through apoptosis and inflammation (Lin et al., 2008) . However, the biological function and physiological regulation of GC-G remains elusive.
In this study, to further explore the possible biological role of GC-G in humans, we identified and characterized the apparent human homologue of GC-G (hGC-G) by the comparative genomic approach. The hGC-G gene, GUCY2GP, resides on human chromosome 10q25.2, spans a minimum of 48 kb, has at least 21 exons, and contains an RGD-motif at the extracellular domain (ECD). This gene is highly expressed in human testis but has a series of differently processed transcripts that contain some insertions, deletions or in-frame termination codons. However, the hGC-G still translates into a receptor-like transmembrane protein and locates on the plasma membrane overlying the acrosome cap and equatorial segment of the sperm head. We further verified by hGC-G RGD and/or hGC-G RGE peptide competition assay that the RGD motif of the hGC-G ECD produces a functional interaction between sperm and oocyte during fertilization. Our results suggest that the hGC-G is a receptor-like cell-surface protein that participates in sperm -oocyte binding through its RGD-containing motif.
Materials and Methods

Reagents and cells
Two independent panels of human tissue cDNAs were obtained from BD-Clontech or OriGene Technologies (Rockville, MD, USA). Highfidelity PfuTurbo polymerase was from Stratagene (La Jolla, CA, USA). The PCR products were cloned into pGEM-T Easy plasmid vector (Promega). Human testis tissue lysate was purchased from BioChain Institute, Inc. (Hayward, CA, USA). Human sperm samples were from the Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Taipei Medical University and Hospital. This study was approved by the institutional ethical and review board of Taipei Medical University for the protection of human subjects.
Database searches and sequence analysis of hGC-G
The coding sequence of mGC-G was first used as a template to search against the human genome database, utilizing the Blat program available from http://www.genome.ucsc.edu. The initial set of BLAST hits was mapped on the human chromosome 10q25.2 region with use of the genome-view option. The sequence of a BAC clone (GenBank accession no. AL157786) containing the hGC-G gene was then downloaded and compared in a pair-wise fashion with the sequence of each individual exon (21 exons) of mGC-G to refine the exon -intron boundaries in the hGC-G gene. The resulting exons corresponding to the putative coding sequence of hGC-G were joined, translated into a protein sequence and analyzed by use of the LASERGENE suite of programs (DNASTAR, Madison, WI, USA).
Tissue distribution of the hGC-G mRNA
Quantitative real-time RT-PCR (TaqMan) analyses involved use of the PRISM 7700 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) with a panel of human fetal and adult tissue cDNAs (BD Clontech, Palo Alto, CA, USA). Normalization was to the level of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA as a control. Probes were designed by use of PrimerExpress software (PE Applied Biosystems) on the basis of the predicted sequence of the hGC-G gene. The gene-specific TaqMan probe was labeled with FAM (6-carboxyfluorescein) at the 5 0 end and BHQ1 (black hole quencher) linked at the 3 0 end as quenchers (Biosource International, Camarillo, CA, USA). The following primers and fluorescent probes were used: for hGC-G, 5 0 primer: tgc cgc agt agg gct tta tc; hGC-G 3 0 primer: gct tcc taa ccc agg ctt ctg; hGC-G probe: 5 0 -FAM-cca tgt ggc cat ccg tta cgt tgg-BHQ1; for GAPDH, 5 0 primer: tga agg tcg gag tca acg g; GAPDH 3 0 primer: aga gtt aaa agc agc cct ggt g, and GAPDH probe: 5 0 -FAM-ttt ggt cgt att ggg cgc ctg g-BHQ1. To confirm the tissue expression of hGC-G, PCR reactions involved use of a pair of hGC-G-specific oligonucleotides (Primer 1; 5 0 -aaa gac atc tgg tgg caa atc-3 0 and Primer 2; 5 0 -ttt ggt tga tga ttt cat ccg-3 0 , Fig. 1 ) from an independent panel of human cDNAs (OriGene Technologies). The resulting PCR products were separated on an agarose gel, transferred onto a nylon membrane and hybridized by use of a [ 32 P]-labeled cDNA probe. Autoradiography was performed at 258C for 15 min.
The tissue distribution of hGC-G transcripts was also analyzed by Southern blot analysis. A fragment of the hGC-G cDNA from a panel of human fetal and adult cDNAs was amplified by PCR with use of specific Novel surface protein expressed on human sperm primers (Primers 1 and 2), then were transferred onto a nylon membrane and hybridized with the hGC-G-specific probe.
Preparation of rabbit polyclonal antisera to hGC-G One peptide, NH 2 -GTPRRSPFRSTISWEEQVSPC-COOH (derived from the ECD of hGC-G), was used as an antigen to immunize New Zealand White rabbits. The rabbits were given an initial subcutaneous injection of 0.5 mg of the recombinant peptide protein emulsified in 1 ml of Freund's complete adjuvant. Subsequently, rabbits received 2 -3 booster injections of 0.25 mg recombinant protein with Freund's incomplete adjuvant. Antisera were recovered from blood obtained by terminal exsanguination and further subjected to Protein-A column processing for partial purification.
Preparation of human sperm and human sperm lysate
The human sperm preparation was as described previously (Brandelli et al., 1994) . In brief, human semen was liquefied at 378C for 60 min, and then separated by 30 -60% Percoll BWW medium (Biggers et al., 1971) . The sperm fraction with good motility was collected after three washes with the same medium to remove semen protein and fatty acid, and then resuspended in defined medium for further use.
The human sperm lysate was prepared as described (Visconti et al., 1995) . In brief, the Percoll-separated human sperm was washed with phosphate-buffered saline (PBS) and then completely lysed in 2Â Laemmli sample buffer with b-mercaptoethanol and boiled for 5 min. After centrifugation at 5000g for 3 min, the supernatant was collected and boiled in the presence of 5% b-mercaptoethanol for 5 min, then subjected to SDS-PAGE as described below.
Preparation of recombinant hGC-G or mGC-G protein
The FLAG-tagged recombinant hGC-G or mGC-G proteins were produced by HEK-293T cells after transient transfection of expression plasmid coding for FLAG.hGC-G or FLAG.mGC-G as described (Kuhn et al., 2004) . The FLAG epitope tag was added at the amino terminus for easy detection of recombinant proteins by western blot analysis or fluorescence-activated cell sorting (FACS) analysis with anti-FLAG antibody.
Western blot analysis of hGC-G
Percoll-separated human sperm cell lysate (20 mg), recombinant protein of FLAG.hGC-G and FLAG.mGC-G, or human testis tissue lysate (20 mg) was boiled in Laemmli sample buffer, separated by SDS-PAGE, and transferred to polyvinylidene difluoride membranes. The membranes were blocked with PBS (pH 7.5) containing 5% skim milk and 0.05% (v/v) Tween-20 and then incubated with four different polyclonal antisera: anti-hGC-G, anti-FLAG, preimmune serum, or control rabbit IgG (10 mg/ml each). After two washes, the blots were incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (1: 2000) (Jackson ImmunoResearch, West Grove, PA, USA) for 1 h. After membranes were washed, the immunoreactive bands were visualized with use of an enhanced chemiluminescence system (ECL; Amersham).
Capacitation and acrosome reaction of human sperm
The Percoll-separated human sperm samples were prepared and resuspended in the Ca 2þ -free BWW medium supplemented with 0.3% bovine serum albumin (BSA) at 2 Â 10 6 cells/ml. For sperm capacitation, human sperm samples in medium were incubated at 378C and 5% CO 2 for 60 -180 min. For sperm acrosome reaction, the capacitated human sperm samples were treated with A23187 (5 mM, Sigma) at 378C and 5% CO 2 for 15 min.
Detection of protein tyrosine phosphorylation
Percoll-purified human sperm samples (5 Â 10 6 cells/ml) in Ca 2þ -free BWW medium were pre-incubated with anti-hGC-G IgG (20 mM), control IgG (20 mM) or control medium at 378C for 15 min, then equal volumes of BSA (0.6%) or control medium with or without anti-hGC-G IgG or control IgG (both 20 mM) were added into the specified culture medium. In the BSA group, the final concentration of BSA was 0.3%. Concentrations of the anti-hGC-G IgG or control IgG remained unchanged. The sperm samples were further incubated at 378C in 5% CO 2 for an additional 3 h. After incubation, the human sperm lysate was collected and underwent 10% SDS-PAGE, and then was transferred to a PVDF membrane for western blot analysis as described previously (Huang et al., 2006) with the primary monoclonal anti-phosphotyrosine IgG (clone 4G10, UBI) (1 mg/ml) and secondary HRP-conjugated anti-mouse IgG antibodies (1: 2000). The enzyme activity of HRP was detected by the ECL system according to the manufacturer's instructions.
Sperm-oocyte binding
To collect oocytes, mature hamster female mice underwent ovulation induction with an injection (intraperitoneal) of pregnant mare serum gonadotrophin (25 IU; Syntex), then were given an intraperitoneal injection of human chorionic gonadotrophin (hCG; 25 IU; Sigma) after 48 h. The oocytes were collected from the oviducts of superovulated animals 12 -13 h after hCG administration. Cumulus cells were removed by incubating the oocyte -cumulus complexes for 3 min in 0.3 mg/ml hyaluronidase (type IV; Sigma). The zona pellucida layers were then dissolved by treating the oocytes with acid Tyrode solution (pH 2.5) for 10 -20 s (Nicolson et al., 1975) . For competition assay of hGC-G RGD or hGC-G RGE peptide on sperm-oocyte binding, the zona pellucida-free oocytes were preincubated with medium containing hGC-G RGD or hGC-G RGE (0.5 mM) at 378C for 2 h. After a brief wash to remove the free hGC-G peptide, the zona pellucida-free oocytes were co-incubated with capacitated sperm (final concentration 10 6 sperm/ml) for 0 -60 min at 378C under 5% CO 2 . The sperm cells adhering to each zona pellucida-free oocyte were counted and analyzed.
Histological and cytological studies
For immunocytochemical staining, freshly prepared human sperm were fixed in 3.7% paraformaldehyde/PBS at room temperature for 30 min in Eppendorf tubes. After fixation, the cells were rinsed with PBS twice, and then treated with PBS containing 0.1% Triton-X 100 (PBST) at room temperature for 10 min and blocked with BSA (5 mg/ml) in PBST for 1 h at room temperature. The cells were then incubated at 48C overnight with the primary anti-hGC-G IgG antibody (10 mg/ml) with gentle shaking. After three washes with PBS, the cells were incubated with the secondary Cy3-conjugated anti-rabbit IgG antibody (1:1000) at room temperature for 1 h. After washes, the sperm cells were counterstained with FITC-PSA (20 mg/ml, Sigma) for acrosome staining and DAPI for nucleus (Sigma). The sperm samples were then smeared on slides, covered with anti-fading reagent (Vector Laboratories), and visualized by epifluorescence (Olympus) and confocal fluorescence microscopy (Leica).
Mature sperm were also collected and stained with anti-hGC-G IgG (10 mg/ml) or control rabbit IgG, then FITC-conjugated anti-rabbit IgG secondary antibody, and were analyzed by FACS analysis.
Statistical analysis
All experiments were repeated at least three times with three different pooled sperm samples. All statistical tests involved use of Graph Pad Instat 3.00 (GraphPad Software, La Jolla, CA, USA). To compare the cell adhesion ability of hGC-G RGD-HEK-293 or hGC-G RGE-HEK-293 cells on a fibronectin (FN)-coated cell plate, we determined the cell adhesion percentage under various experimental conditions and then compared each other by one-way ANOVA, followed by the Tukey-Kramer multiple comparison test. To compare the binding ability of hGC-G RGD-or hGC-G RGE-pretreated sperm cells on zona pellucidafree oocytes, the sperm number on each oocyte was counted and compared by unpaired t test. The data are expressed as means + SD, and P , 0.05 was considered statistically significant.
Results
In silico identification and sequence analysis of hGC-G
The nucleotide sequence of mGC-G (GenBank accession no. AY395631) derived from our previous report (Kuhn et al., 2004) was used for a homology search in the human genome database (www.genome.ucsc.edu). The hGC-G gene, GUCY2GP, is contained in a BAC clone (GenBank accession no. AL157786) localized to chromosome 10q25.2 and is syntenic to mouse chromosome 19.D2, where the mGC-G gene resides. The gene structure and exonintron boundaries appear to be well conserved between mGC-G and hGC-G genes, and the nucleotide sequences of the predicted mGC-G and hGC-G genes showed an overall 80% identity in coding region.
Despite a high degree of sequence identity with mGC-G, hGC-G had three 1-bp deletions and two in-frame termination codons as compared with the mouse orthologue. The first 1-bp deletion (Deletion I) is located within the ECD ( Supplementary Fig. S1 ), and the other two (Deletions II and III) reside towards the carboxyl-terminal end of the cyclase catalytic domain ( Supplementary Fig. S2 ). In addition, two in-frame termination codons (Stop I and II) are present within the kinase-like domain ( Supplementary Fig. S2 ). Thus, GUCY2GP spans a minimum of 48 kb and contains at least 21 exons (Fig. 1) . Multiple alignment analysis comparing the putative hGC-G protein sequence with that of rat and mGC-G showed an overall 65% sequence similarity ( Supplementary Fig. S3 ). Four cysteine residues within the ECD of GC-G are conserved among these orthologues. These cysteine residues are also invariant in other receptor GCs (Thompson and Garbers, 1995) and play an important role in maintaining the proper disulfide bonding and the ligand-binding function of receptor GCs (McNicoll et al., 1996; van den Akker et al., 2000) .
Tissue-specific expression of hGC-G
We first used a sensitive PCR-based approach to determine the tissue distribution of hGC-G. The hGC-G-specific oligonucleotide primers and probes were designed on the basis of gene prediction to study the tissue expression profile by quantitative real-time RT-PCR (TaqMan) analysis. Among human fetal and adult tissues, hGC-G mRNA was highly expressed in the testis, and then showed a lower expression in placenta but virtually no expression in all other tissues examined ( Fig. 2A) . Similar results were obtained from an independent panel of tissue cDNAs by a combination of RT -PCR then Southern blot analysis (Fig. 2B ). Together, these results clearly demonstrate that, like mGC-G, hGC-G is a testis-enriched gene (Kuhn et al., 2004) .
Expression and localization of hGC-G in sperm
To investigate whether the putative hGC-G is indeed expressed at the protein level, we generated an anti-hGC-G-specific polyclonal antibody. As shown in Fig. 3A , the antiserum could specifically detect the recombinant hGC-G protein (FLAG-tagged hGC-G) but not the FLAG-tagged mGC-G receptor in HEK-293T cells. Preimmune serum served as a negative control. The cell-surface expression of recombinant hGC-G on HEK-293T cells was further confirmed by flow cytometry (Fig. 3B) .
We then performed western blot analysis to examine the protein expression of hGC-G in human sperm and testis. The human sperm was pre-separated by Percoll gradient to remove semen protein and fatty acid. As shown in Fig. 4A , as compared with the rabbit IgG control, anti-hGC-G IgG detected several specific immunoreactive bands from human sperm extracts (30-50 kDa, Cleaved). In addition, the molecular identity of hGC-G in the testis was further examined. Figure 4A showed that the anti-hGC-G IgG recognized a testis-specific protein with an apparent molecular mass of 70 kDa (asterisk), which supports the existence of an unprocessed hGC-G precursor in testis. Further immunocytochemical staining combined with flow cytometry revealed its characteristics in cell surface expression ( Fig. 4B ). Further, in conjunction with epifluorescence and confocal image analysis, hGC-G was shown to be located at the tail, acrosomal cap and equatorial segment ( Fig. 4C and D) .
Effect of hGC-G on sperm capacitation
Because hGC-G located both at the tail and head of human sperm, we determined the role of hGC-G in sperm activation and/or fertilization. Because of a lack of known ligand or specific inhibitor for hGC-G, we tested the function of hGC-G in sperm activation by using the 'BSA activation assay model' as we reported previously (Huang et al., 2006) . The protein tyrosine phosphorylation is known to be molecular evidence for sperm capacitation (Carrera et al., 1996 , Zarelli et al., 2009 . Therefore, we used the anti-hGC-G-specific IgG antibody raised against a peptide immunogen within the ECD as a neutralizing reagent and detected the protein tyrosine phosphorylation level of human sperm under BSA (0.3%) treatment in the presence of the anti-hGC-G IgG or the control rabbit IgG. Consistent with a previous report, the human sperm showed a Ca 2þ -dependent suppression of protein tyrosine phosphorylation (Carrera et al., 1996) (Fig. 5, lanes 2, 4, 6 and 8 versus  lanes 1, 3, 5 and 7) . In addition, the tyrosine phosphorylation of proteins of 40-105 kDa was significantly enhanced in a time-dependent manner when sperm samples were incubated in 0.3% BSA-BWW media containing no added Ca 2þ (Fig. 5, lanes 3, 5 and 7) . Preincubation with the anti-hGC-G IgG or the control IgG had no effect on the profiles of BSA-induced tyrosine phosphorylation of proteins in the absence of Ca 2þ (Fig. 5, lanes 9 or 10 versus lane 5) or in the presence of Ca 2þ (data no shown). As well, human sperm motility was not affected by incubation with the anti-hGC-G IgG (data not shown). Together, our data suggest that hGC-G may not be involved in human sperm capacitation. (Primers 1 and 2, Fig. 1 ), then were transferred onto a nylon membrane and hybridized with a hGC-G-specific probe. cDNA templates used were (1) brain, (2) heart, (3) kidney, (4) spleen, (5) liver, (6) colon, (7) lung, (8) small intestine, (9) muscle, (10) stomach, (11) testis, (12) placenta, (13) salivary, (14) thyroid, (15) adrenal gland, (16) pancreas, (17) ovary, (18) uterus, (19) prostate, (20) skin, (21) peripheral blood leukocytes, (22) bone marrow, (23) fetal brain and (24) fetal liver. Note that the apparent size difference of GC-G transcripts between testis and placenta may represent the differential splice variants expressed in these tissues.
Figure 3 Expression of recombinant hGC-G protein on HEK-293T
cells.
(A) Specificity of anti-hGC-G antibody. Anti-hGC-G polyclonal antiserum was generated in rabbits immunized with the peptide immunogen derived from the extracellular domain of hGC-G and purified by a protein A-affinity column as described in 'Materials and Methods'. The anti-hGC-G antibody could specifically recognize the recombinant FLAG-tagged hGC-G (FLAG.hGC-G) protein expressed in HEK-293T cells but not the FLAG-tagged mGC-G (upper panel). As a control, protein expression of the FLAG-tagged GC receptors was confirmed by anti-FLAG antibody. Molecular masses are indicated in kDa. (B) Cell-surface expression of recombinant hGC-G by flow cytometry. HEK-293T cells transiently transfected with the empty vector (Vector) or the expression plasmid encoding FLAG.hGC-G protein were stained with anti-FLAG (10 mg/ml), then an FITC-conjugated anti-mouse IgG secondary antibody, and then analyzed by fluorescence-activated cell sorting (FACS) analysis.
Effect of hGC-G RGD motif on sperm -oocyte recognition
In comparing amino acid sequences, we found that hGC-G contains an RGD motif located in exon 4 of the ECD domain (Supplementary Fig. 1) . The RGD motif present in extracellular matrix proteins or membrane-anchored proteins is known to specifically bind with integrin complexes. To examine the binding ability of hGC-G to integrins, we used HEK-293T (integrin expression)-FN (RGD-motif containing) cell binding as a cell platform to test the competition ability of the hGC-G-RGD peptide (12 amino acids long, Table I) on HEK-293T cell binding to the FN-coated culture plate. As shown in Fig. 6A , the cell adhesion percentage of 293T cells on the FN-coated culture plate was much higher than that of the uncoated group (**P , 0.001). The addition of the hGC-G RGD peptide significantly suppressed the binding of the HEK-293T cells on the FN-coated culture plate in a dose-dependent manner (*P , 0.05, **P , 0.001), whereas the non-adhesive mutated hGC-G RGE peptide (12 amino acids long, Table I ) had no effect on the cell-matrix binding and thus served as a control (Fig. 6A) .
Integrin is known to be expressed on the ooplasm of oocytes (Nixon et al., 2007) . Given that hGC-G contains an RGD motif and is located at the acrosome cap and equatorial segment of sperm, we then detected whether the hGC-G RGD motif mediated the recognition of human sperm and oocytes. Zona pellucida-free hamster oocytes were pre-incubated with hGC-G RGD or hGC-G RGE peptide at 378C for 2 h, and then co-incubated with activated human sperm at 378C for 0-60 min. We analyzed the adhesive sperm number on hamster zona pellucida-free oocytes. As shown in Fig. 6B , as compared with the hGC-G RGE peptide pre-incubation, hGC-G RGD peptide pre-incubation significantly suppressed the binding of human sperm on the zona pellucida-free hamster oocyte (**P , 0.001). These results suggest the potential role of the hGC-G-RGD-containing motif in mediating sperm -oocyte recognition. 
Discussion
In this study, we demonstrated that hGC-G is a human sperm cellsurface receptor-like polypeptide and uncovered its role in spermoocyte interaction, the critical and complex molecular event for successful fertilization. Recent research in conjunction with genomic and proteomic techniques has uncovered a number of putative cell-surface molecules that regulate the sperm -oocyte interaction; however, the recognition molecules have still remained unclear.
GC-G is the most recent member of the receptor GC family to be identified (Schulz et al., 1998; Kuhn et al., 2004) . The full-length cDNA for mGC-G (Gucy2g) was recently identified and originally isolated from the testis (Kuhn et al., 2004) . The biological function of the mGC-G protein is sperm activation (Huang et al., 2006) and early signaling in response to ischemia -reperfusion (I/R)-induced acute renal injury (Lin et al., 2008) . However, in comparison with the role of GC-G in the mouse model, that in the human orthologue hGC-G was unclear.
To further define the possible biological function of hGC-G, we identified the apparent homologue of GC-G in humans by a comparative genomic approach. Similar to mGC-G mRNA, hGC-G mRNA was selectively and highly expressed in human testis. In addition, in comparison to the mouse orthologue, hGC-G showed high similarity in a conserved allelic gene sequence but with some deletions in the ECD, the cyclase catalytic domain, as well as in-frame termination codons in the deduced coding sequence of cytosolic kinase-like domain. Because of defects in the deduced coding sequence of the kinase-like and cyclase domain, which respond with cGMP-mediated signaling, hGC-G was tentatively suggested to be a non-functional protein (Kuhn, 2009) .
In our experiments, we found that although hGC-G contains some defects in gene sequence, it is still expressed as a receptor-like protein in structure. Further experiments by western blot analysis with a specific antibody showed that the hGC-G protein is expressed in ejaculated human sperm. In addition, use of immunocytochemical staining in combination with flow cytometry, epifluorescence and confocal imaging revealed that hGC-G is localized both on the acrosomal cap and equatorial segment of the human sperm head. The equatorial segment protein of sperm head is important for successful fertilization (Wolkowicz et al., 2008) . Many sperm equatorial-segment proteins have been reported to mediate the sperm -oocyte interaction; examples are: mouse SLLP1 (mouse sperm lysozyme-like protein), located in the equatorial segment of mouse and human spermatozoa (Herrero et al., 2005) ; oxidoreductase ERp57 (Pdi3a, localized on the plasma membrane overlaying the equatorial segment of mouse sperm) (Ellerman et al., 2006) ; and Izumo (a novel member of the immunoglobulin superfamily located on the inner acrosomal membrane and equatorial segment of mouse sperm) (Inoue et al., 2005) . Thus, the strategic localization of hGC-G on the sperm acrosomal membrane and equatorial segment strongly implies its role in sperm -oocyte interaction.
Furthermore, we found that an RGD-containing motif is present in the coding sequence within the hGC-G ECD domain. The RGD-containing motif is known to interact with integrin to promote cell-cell or cell-extracellular matrix interactions (Huveneers et al., 2007) . In the sperm-oocyte interaction, the RGD-containing motif of sperm cell-surface proteins has been hypothesized to serve as a recognition site for oocyte binding. Pre-incubation of RGD peptides with oocytes inhibits the sperm -oocyte interaction in the hamster or bovine (Bronson and Fusi, 1990; Shrimali and Reddy, 2000; Eto et al., 2002) . For example, the ADAM family of sperm cell-surface proteins, such as fertilin a/b (ADAM1/2) and cyritestin (ADAM3), provide the RGD motif to bind integrin a6b1 on oocytes to promote successful fusion (Primakoff and Myles, 2000) . However, fertilin b-null sperm still showed 50% of the successful sperm -oocyte fusion rate, and cyritestin-null sperm showed 100% of the wild-type rate. Furthermore, double knockout of fertilin b and cyritestin in mice showed fusion at 50% of the wild-type rate (Cho et al., 1998; Nishimura et al., 2001) . In addition, recent reports of CD46 2/2 (Inoue et al., 2003) as well as CRISP1 2/2 (Da Ros et al., 2008) also showed no difference in fertility as compared with the control group. These results strongly suggest that the potential candidate gene for sperm-oocyte interaction still requires further validation by a gene targeting approach. Together, multiple cooperation systems must exist in the sperm -oocyte interaction to facilitate gamete fusion efficiency in physiology.
In our experiments, hGC-G seemed not to be involved in capacitation-associated protein tyrosine phosphorylation of human spermatozoa. However, pre-incubation of hGC-G-RGD peptide Percoll-purified human sperm were incubated in Ca 2þ -depriving or Ca 2þcontaining BWW medium alone for 60-180 min; or were pre-treated with the supplemented anti-hGC-G IgG (20 mM) or control IgG (20 mM) in Ca 2þdepriving BWW medium for 15 min, and then incubated with BSA for 90 min (0.3% in a final concentration supplemented with rabbit IgG or anti-hGC-G IgG) to induce protein tyrosine phosphorylation (see 'Materials and Methods'). Relative protein tyrosine phosphorylation in human sperm samples was measured by western blot analysis with anti-phosphotyrosine antibody. Molecular masses are indicated in kDa. with hamster oocytes significantly reduced the binding ability of human spermatozoa on zona pellucida-free hamster oocytes. Together, our data suggest that the equatorial-segment protein hGC-G may play a role in sperm -oocyte interaction through its RGD motif. Of note, we tested, but did not observe an inhibitory effect of anit-hGC-G IgG on sperm adhesion to oocytes. These results may be due to this antibody being raised by a peptide immunogen distinct from the RGD motif site, therefore not targeting the non-RGD site. However, we cannot formally exclude that the RGD peptide may target other sperm protein(s) other than hGC-G. Regardless, further studies producing additional specific anti-hGC-G antibodies against the adhesive RGD motif are important to clarify this issue. Within the GC gene family, hGC-D, like hGC-G, was proposed to be a pseudogene in humans by genomic prediction (Potter, 2005) . However, unlike the hGC-G gene, which still codes for a receptor-like product containing the ECD, transmembrane domain, and partial kinase domain, the hGC-D gene contains large deletions of exons 2/4/5, which almost remove the ECD and transmembrane domain. In addition, deletion of exons 4/5 leads to a frame shift and truncates the protein before the kinase and catalytic domains. Thus, the GC-D gene was suggested to be degenerated during primate evolution (Young et al., 2007) .
In this respect, in terms of gene and protein level, we have demonstrated hGC-G expression by a genomic approach, mRNA/protein detection and cellular localization. In protein expression, western blot analysis revealed a proteolytic process of hGC-G similar to mGC-G during sperm maturation (Fig. 4A, testis panel) . A similar proteolytic modification of fertilin a/b also plays important roles in sperm -oocyte recognition (Blobel et al., 1990) . The proteolytic processing of fertilin, and perhaps other sperm proteins, has been suggested to trigger the relocalization of fertilin from the whole sperm head to the posterior head to expose an epitope for sperm -oocyte interactions (Blobel, 2000) . Likewise, an hGC-G fragment anchored on the sperm surface may use a similar proteolytic processing to expose its RGD-containing motif and exert its biological function in the sperm-oocyte interaction.
In summary, we demonstrated that the hGC-G is a cell-surface protein expressed on the acrosomal and equatorial segment of human sperm, and this novel GC receptor may participate in sperm -oocyte interaction through its RGD-containing motif. Functional study of the proposed pseudogene hGC-G could shed some light on the possible biological function of this pseudogene family identified by genomic research. Figure 6 Effect of hGC-G RGD motif in sperm-oocyte interaction.
(A) The binding ability of hGC-G-RGD to integrin. The competition ability of hGC-G-RGD or hGC-G-RGE peptide on the interaction of 293T cells (with integrin) to fibronectin (FN, 10 mg/ml) is shown. The cell adhesion percentage of 293T cells on the FN-coated culture plate is much higher than that without FN-coated (**denotes that the difference in cell adhesion percentage on the FN-coated plate is significant at P , 0.001). The inhibition effect of hGC-G RGD peptide (0, 0.5, 1.0 and 1.5 mM) or hGC-G-RGE (1.5 mM) on the cell adhesion percentage of 293T cells on the FN-coated culture plate was examined (*P , 0.05, **P , 0.001). (B) Effect of hGC-G RGD peptide or hGC-G RGE (0.5 mM) on adhesion of sperm and zona pellucida-free oocytes. **denotes that the difference from the hGC-G RGE pretreatment is significant at P , 0.001. Represents mean + SD of at least three independent determinations for each condition.
